Research powered investment banking
Home
Research
Companies
Find Alpha
Themes
Top Picks
Premium
Transactions
Events
Redeye
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Members network
Community
sign in
Member sign in
Join redeye
Home
research
Companies
Find Alpha
Themes
Top Picks
Transactions
Events
redeye
About
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Community
The latest from Redeye about Scandinavian Life Science and Technology companies
Moberg Pharma
Question marks straightened out, but uncertainty about approval in the US remains
Calliditas Therapeutics
Brief comment on the PIP
Stillfront Group
Mega acquisition
Better Collective
Betting on 2020 - Adding to our Conviction Buy List
AroCell
Funding secured, next step - FDA
Cimco Marine
Time to rev up sales
Artificial Solutions
Guidance cut and a tough rights issue
Speqta
Positive first impression of major acquisition
Karolinska Development
Where we stand after resolved on short-term finances
Episurf Medical
Important steps taken in the production process
Proact IT
We cut 2020 EBITA by 12%
Premium
Redeye Tech Report 2020
Rapport på 192 sidor